Pelayaran Nasional Ekalya Purnamasari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Pelayaran Nasional Ekalya Purnamasari Tbk. trades at Rp1,025 (market cap 7.59T, 795.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 60.7K 24h volume). The key difference: Pelayaran Nasional Ekalya Purnamasari Tbk. is far larger — about 45.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Pelayaran Nasional Ekalya Purnamasari Tbk. is more actively traded (795.6K versus 60.7K). Which is the better fit depends on your goals.
| ELPI | OBAT | |
|---|---|---|
Market Cap | 7.59T | 167.37B |
Volume | 795.6K | 60.7K |
Lot | 7.96K | 607 |
Turnover | 810.55M | 14.94M |
Average Price | 1,018.79 | 246.07 |
Value | 810.55M | 14.94M |
Indicative Equilibrium Price | 990 | 246 |
Indicative Equilibrium Volume | 18.1K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Pelayaran Nasional Ekalya Purnamasari Tbk (the Entity) was established based on Notarial Deed No. 11 of Grace Margareth Goenawan, S.H., dated April 20, 1992 in Ambon. PT Pelayaran Nasional Ekalya Purnamasari is the parent Entity, whereas PT Kreasi Cipta Timur is the ultimate parent of the Entity. The Entity’s Ultimate Beneficiary Ownership (UBO) is Eka Taniputra.
Read more on ELPI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →